PRECIGEN, INC. Increase Decrease In Operating Lease Liability
PRECIGEN, INC. (PGEN) reported Increase Decrease In Operating Lease Liability of -$107.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-04
- PRECIGEN, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$32.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$75.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$4.00K, a 180.00% decline year-over-year.
- PRECIGEN, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $94.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for fiscal 2025 was -$9.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for fiscal 2024 was -$55.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for fiscal 2023 was -$107.00K.
- PRECIGEN, INC. increase decrease in operating lease liability for fiscal 2022 was -$107.00K, a 210.31% decline from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$107.00K 10-Q · filed 2026-08-04 | -$111.00K derived: sum of 3 quarters · filed 2026-08-04 | -$17.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$75.00K 10-Q · filed 2026-05-13 | -$79.00K derived: sum of 2 quarters · filed 2026-05-13 | $15.00K derived: sum of 3 quarters · filed 2026-05-13 | $11.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $90.00K derived: sum of 2 quarters · filed 2026-03-25 | $86.00K derived: sum of 3 quarters · filed 2026-08-04 | -$9.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $90.00K derived: sum of 2 quarters · filed 2026-08-04 | -$5.00K 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$99.00K 10-Q · filed 2026-08-04 | -$94.00K derived: sum of 3 quarters · filed 2026-08-04 | -$457.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$95.00K 10-Q · filed 2026-05-13 | -$90.00K derived: sum of 2 quarters · filed 2026-05-13 | -$453.00K derived: sum of 3 quarters · filed 2026-05-13 | -$190.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$358.00K derived: sum of 2 quarters · filed 2026-03-25 | -$95.00K derived: sum of 3 quarters · filed 2026-03-25 | -$55.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$363.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$100.00K derived: sum of 2 quarters · filed 2025-11-13 | -$60.00K 10-Q · filed 2025-11-13 | -$247.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $303.00K 10-Q · filed 2025-08-12 | $116.00K derived: sum of 3 quarters · filed 2026-03-25 | -$33.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $40.00K 10-Q · filed 2025-05-14 | -$147.00K derived: sum of 2 quarters · filed 2026-03-25 | -$296.00K derived: sum of 3 quarters · filed 2026-03-25 | -$262.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$336.00K derived: sum of 2 quarters · filed 2026-03-25 | -$302.00K derived: sum of 3 quarters · filed 2026-03-25 | -$107.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$115.00K derived: sum of 2 quarters · filed 2024-11-14 | $80.00K 10-Q · filed 2024-11-14 | $52.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $229.00K 10-Q · filed 2024-08-14 | $201.00K derived: sum of 3 quarters · filed 2025-03-19 | $162.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $195.00K 10-Q · filed 2024-05-14 | $167.00K derived: sum of 2 quarters · filed 2025-03-19 | $128.00K derived: sum of 3 quarters · filed 2025-03-19 | $106.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$67.00K derived: sum of 2 quarters · filed 2025-03-19 | -$89.00K derived: sum of 3 quarters · filed 2025-03-19 | -$107.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$61.00K derived: sum of 2 quarters · filed 2023-11-09 | -$79.00K 10-Q · filed 2023-11-09 | -$89.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$40.00K 10-Q · filed 2023-08-09 | -$50.00K derived: sum of 3 quarters · filed 2024-03-19 | -$88.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | -$18.00K 10-Q · filed 2023-05-10 | -$28.00K derived: sum of 2 quarters · filed 2024-03-19 | -$66.00K derived: sum of 3 quarters · filed 2024-03-19 | -$139.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$48.00K derived: sum of 2 quarters · filed 2024-03-19 | -$121.00K derived: sum of 3 quarters · filed 2024-03-19 | $97.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$111.00K derived: sum of 2 quarters · filed 2022-11-09 | $107.00K 10-Q · filed 2022-11-09 | -$272.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $145.00K 10-Q · filed 2022-08-08 | -$234.00K derived: sum of 3 quarters · filed 2023-03-06 | |
| 2021-03-31 | $218.00K 10-Q · filed 2022-05-09 | -$161.00K derived: sum of 2 quarters · filed 2023-03-06 | ||
| 2020-12-31 | -$379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$887.00K 10-K · filed 2023-03-06 | ||
| 2020-09-30 | -$508.00K 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | -$995.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |